The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis.
作者: Han TaoYang XiaodanZhang YueLi GaoLiu LuChen TingsongZheng Zhendong
作者单位: 1Department of Oncology, Cancer Center, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
2Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.
3Department of Invasive Technology, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
刊名: Bioscience trends, 2019, Vol.13 (5), pp.374-381
来源数据库: PubMed Journal
DOI: 10.5582/bst.2019.01153
关键词: DEB-TACETACELiver cancerObjective response rateSafetySurvival
原始语种摘要: Transcatheter arterial chemoembolization (TACE) plays an important role in the treatment of unresectable liver cancer. We conducted this meta-analysis to compare the clinical safety and efficacy of conventional TACE (C-TACE) and drug-eluting beads (DEB)-TACE. A search for those procedures was performed using the PubMed, EMBASE, and Cochrane Library databases. A meta-analysis of patients who underwent C-TACE or DEB-TACE was conducted. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Of 334 studies, 30 were analyzed. The complete response rate, disease control rate, objective response rate, 3-year survival rate, and non-response rate were significantly higher in patients who underwent DEB-TACE than those in patients who underwent C-TACE. The 1-year survival rate, 2-year...
全文获取路径: PubMed  (合作)
影响因子:1.582 (2012)

  • transcatheter 输导管
  • unresectable 不可切除的
  • hepatocellular 肝细胞性的
  • arterial 动脉的
  • eluting 洗脱
  • carcinoma 癌症
  • efficacy 效验
  • survival 生存
  • conventional 常规
  • response 响应